Presenter: James McCormack Pharm D Mike Kolber MD MSc CCFP Tony Nickonchuk BScPharm
In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the evidence addresses the issue of primary versus secondary prevention. We then give you all the numbers and the context you need to allow you to…
BS Medicine Episode #624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?
FM Rounds #20: Accompagner les personnes trans et non binaires en médecine familiale
FM Rounds #19: Coming Home: Post-op Gender Affirming Surgery in Primary Care
Presenter(s):
James McCormack Pharm D Mike Kolber MD MSc CCFP Tony Nickonchuk BScPharm








Please provide any additional comments (optional).